SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Healixa Inc. (EMOR) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 22/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — EMOR
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio54.54
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2011 |
$-0.07 |
$36.68K |
$-330.67K |
-901.5% |
| 2012 |
$-0.05 |
$64.24K |
$-419.5K |
-653.1% |
| 2017 |
$0.00 |
$9.65K |
$-49.61K |
-514.4% |
| 2018 |
$-0.01 |
$6.72K |
$-336.73K |
-5007.8% |
| 2019 |
$0.00 |
$117.93K |
$-1.11M |
-938.6% |
| 2020 |
$-0.02 |
$59.45K |
$-15.06M |
-25329.4% |
| 2021 |
$0.00 |
$0.00 |
$-2.84M |
- |
| 2022 |
$0.00 |
$8.82K |
$-645.42K |
-7316.1% |
| 2023 |
$-0.01 |
$598.89K |
$-6.73M |
-1123.8% |
| 2024 |
$0.00 |
$702.91K |
$-756.9K |
-107.7% |
